PLoS ONE · 2022 · 12 citations · 15 references
Our observational study demonstrates that PFO closure for prevention of recurrent stroke is a relatively safe procedure but in routine clinical practice is associated with a slightly higher risk of recurrent neurological events than in randomised trials. We hypothesize that our study enrolled unselected patients with higher baseline risk, who were excluded from randomised trials, but who may benefit from a similar relative reduction in risk from the intervention.
15
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
Jean‐Louis Mas, Geneviève Dérumeaux, B. Guillon et al. · New England Journal of Medicine · 2017 · 1.1K citations · Full text
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
Lars Søndergaard, Scott E. Kasner, John F. Rhodes et al. · New England Journal of Medicine · 2017 · 1.1K citations